AR and prostate carcinoma: For instance, miRNAs have been shown to negatively regulate the expression of estrogen receptor-α and estrogen receptor-β (149–152), and a study by Epis et al., 2009, suggests that miR-331-3p regulates androgen receptor (AR)-mediated signaling in prostate cancer cell lines (153).